Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
VESPER-3: the monthly maintenance experiment Pfizer describes VESPER-3 as an ongoing Phase 2b study evaluating monthly maintenance dosing in adults with obesity/overweight without type 2 diabetes
It's an ideal choice for those seeking an effective and simple solution to jump start your weight loss journey
Choosing your target maintenance dose The right maintenance dose depends on several factors: Remember that you can always adjust your target dose based on how you respond
Reduced Glucagon Production : It restricts glucagon, minimizing the liver's tendency to produce more glucose, and helping stabilize blood glucose levels
US$ 20.80
US$ 22.89
US$ 27.18
US$ 27.34
